We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. The effect of transcranial alternating current stimulation on cognitive flexibility and attention of children with intellectual disability: a case report

    Background

    Intellectual disability is a neurodevelopmental disorder characterized by significant impairments in intellectual functioning and adaptive...

    Zahra Ghahri Lalaklou, Elahe Haghighat-Manesh, ... Ezzatollah Ahmadi in Journal of Medical Case Reports
    Article Open access 05 July 2024
  2. Symptomatic remission and its associated factors among patients with schizophrenia on risperidone or olanzapine at Amanuel mental specialized hospital, Addis Ababa, Ethiopia

    Background

    Schizophrenia is a debilitating condition that affects 1% of the global population. Understanding the prevalence and the factors predicting...

    Melak Gedamu Beyene, Solomon Teferra, Teferi Gedif Fenta in Middle East Current Psychiatry
    Article Open access 05 July 2024
  3. Sexuelles Verlangen natürlich steigern

    Redaktion Facharztmagazine in gynäkologie + geburtshilfe
    Article 05 July 2024
  4. Brustkrebs interdisziplinär betrachet

    Redaktion Facharztmagazine in gynäkologie + geburtshilfe
    Article 05 July 2024
  5. Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trial

    Background

    Recently we reported results of phase 1 pilot clinical trial of 2 consecutive intracavernous (IC) injection of autologous bone...

    Saddam Al Demour, Sofia Adwan, ... Abdalla Awidi in Basic and Clinical Andrology
    Article Open access 05 July 2024
  6. Sample size calculation for data reliability and diagnostic performance: a go-to review

    Sample size, namely the number of subjects that should be included in a study to reach the desired endpoint and statistical power, is a fundamental...

    Caterina Beatrice Monti, Federico Ambrogi, Francesco Sardanelli in European Radiology Experimental
    Article Open access 05 July 2024
  7. Impfen in der gynäkologischen Praxis

    Cornelia Hösemann in gynäkologie + geburtshilfe
    Article 05 July 2024
  8. Mikronährstoffe: mehr als nur Folsäure

    Redaktion Facharztmagazine in gynäkologie + geburtshilfe
    Article 05 July 2024
  9. Religious Differences in Physical and Mental Health among Israeli Jews: Findings from the Global Flourishing Study

    Numerous studies have identified religious correlates of health indicators, but relatively few have been conducted among Jewish populations in Israel...

    Jeff Levin, Matt Bradshaw, Byron R. Johnson in Journal of Religion and Health
    Article 05 July 2024
  10. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis

    Background and Aims

    The risk of hepatocellular carcinoma (HCC) occurrence following antiviral therapy in patients with chronic hepatitis C (CHC)...

    Gui-Ji Lv, Dong Ji, ... Zhi-Liang Gao in Hepatology International
    Article 05 July 2024
  11. Clinical efficacy of a new therapeutic option for lower genital tract lesions: 5-ALA photodynamic therapy

    The study utilized 5-ALA-PDT to treat patients with CIN or VaIN and assessed their clinical response, HPV clearance, and influencing factors after...

    Yingzhen Liu, Hekabakila-Banzouzi Medlege, ... Yan Tian in Lasers in Medical Science
    Article 05 July 2024
  12. Risk factors for Non-Hodgkin’s lymphoma in autoimmune disease: a large database analysis

    Immune dysregulation in autoimmune diseases (ADs) is a risk factor for the development of Non-Hodgkin’s lymphoma (NHL). However, the underlying...

    Suma Sri Chennapragada, Shriya Goyal, ... Poornima Ramadas in Annals of Hematology
    Article 05 July 2024
  13. A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

    Background

    In 2008, bevacizumab received accelerated Food and Drug Administration (FDA) approval for use in human epidermal growth factor receptor 2...

    Jessica Mezzanotte-Sharpe, Anne ONeill, ... Sonya A. Reid in Breast Cancer Research and Treatment
    Article Open access 05 July 2024
Did you find what you were looking for? Share feedback.